These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

683 related items for PubMed ID: 1619742

  • 1. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
    Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE.
    JAMA; ; 268(4):504-9. PubMed ID: 1619742
    [Abstract] [Full Text] [Related]

  • 2. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
    Caiaffa WT, Graham NM, Galai N, Rizzo RT, Nelson KE, Vlahov D.
    Arch Intern Med; 1995 Oct 23; 155(19):2111-7. PubMed ID: 7575072
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis.
    Gourevitch MN, Hartel D, Selwyn PA, Schoenbaum EE, Klein RS.
    AIDS; 1999 Oct 22; 13(15):2069-74. PubMed ID: 10546859
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.
    Graham NM, Nelson KE, Solomon L, Bonds M, Rizzo RT, Scavotto J, Astemborski J, Vlahov D.
    JAMA; 1992 Jan 15; 267(3):369-73. PubMed ID: 1727959
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk for developing tuberculosis among anergic patients infected with HIV.
    Moreno S, Baraia-Etxaburu J, Bouza E, Parras F, Pérez-Tascón M, Miralles P, Vicente T, Alberdi JC, Cosín J, López-Gay D.
    Ann Intern Med; 1993 Aug 01; 119(3):194-8. PubMed ID: 8100693
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
    Jansà JM, Serrano J, Caylà JA, Vidal R, Ocaña I, Español T.
    Int J Tuberc Lung Dis; 1998 Feb 01; 2(2):140-6. PubMed ID: 9580481
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The incidence of tuberculosis in drug users with small tuberculin reaction sizes.
    Klein RS, Gourevitch MN, Teeter R, Schoenbaum EE.
    Int J Tuberc Lung Dis; 2001 Aug 01; 5(8):707-11. PubMed ID: 11495260
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stability of cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiology Research Study Group.
    Klein RS, Sobel J, Flanigan T, Smith D, Margolick JB.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar 01; 20(3):238-44. PubMed ID: 10077171
    [Abstract] [Full Text] [Related]

  • 16. Lack of association of induration size with HIV infection among drug users reacting to tuberculin.
    Gourevitch MN, Hartel D, Schoenbaum EE, Klein RS.
    Am J Respir Crit Care Med; 1996 Oct 01; 154(4 Pt 1):1029-33. PubMed ID: 8887602
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.
    Scholten JN, Driver CR, Munsiff SS, Kaye K, Rubino MA, Gourevitch MN, Trim C, Amofa J, Seewald R, Highley E, Fujiwara PI.
    Clin Infect Dis; 2003 Dec 15; 37(12):1686-92. PubMed ID: 14689352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.